Cargando…
ADAM-12 as a Diagnostic Marker for the Proliferation, Migration and Invasion in Patients with Small Cell Lung Cancer
Small cell lung cancer (SCLC) is highly aggressive and is characterized by malignant metastasis. Approximately 90% of patients die due to extensive metastasis. The extracellular matrix (ECM) is a natural barrier that can prevent cellular invasion and metastasis. Therefore, degradation of the ECM mus...
Autores principales: | Shao, Shuhong, Li, Zunling, Gao, Wei, Yu, Guohua, Liu, Dexiang, Pan, Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897605/ https://www.ncbi.nlm.nih.gov/pubmed/24465799 http://dx.doi.org/10.1371/journal.pone.0085936 |
Ejemplares similares
-
ADAM 12: A Putative Marker of Oligodendrogliomas?
por: Kanakis, Dimitrios, et al.
Publicado: (2013) -
HHIP overexpression inhibits the proliferation, migration and invasion of non-small cell lung cancer
por: Zhao, Jian-Guo, et al.
Publicado: (2019) -
MiR-449a regulates the cell migration and invasion of human non-small cell lung carcinoma by targeting ADAM10
por: Meng, Haining, et al.
Publicado: (2019) -
Proteolytic cleavage of amyloid precursor protein by ADAM10 mediates proliferation and migration in breast cancer
por: Tsang, Julia Y.S., et al.
Publicado: (2018) -
SERINC2-knockdown inhibits proliferation, migration and invasion in lung adenocarcinoma
por: Zeng, Yuan, et al.
Publicado: (2018)